Optofluidic Bioassay is a University of Michigan spin-off that specializes in developing microfluidic technologies to enhance the efficiency and accessibility of ELISA (enzyme-linked immunosorbent assay). Their innovative solutions, such as the MicroFluere and Xpress ELISA, utilize microfluidics to significantly reduce assay time, increase dynamic range, and minimize reagent use, making biomolecular analysis faster and more cost-effective.
With a focus on revolutionizing biomolecular analysis, Optofluidic Bioassay is dedicated to providing cutting-edge solutions for various applications. Their Xpress ELISA, currently under development, aims to enable point-of-care diagnosis with its compact size, fast assay turnaround, and low-cost assays. Additionally, their planned Personal ELISA device focuses on in-home monitoring, offering Bluetooth integration with smartphone apps and emphasizing prevention and early disease intervention for individuals with family history or chronic diseases.
Generated from the website